-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Amrize, Lowers Price Target to $46

Benzinga·11/19/2026 19:15:15
JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Neutral and lowers the price target from $48 to $46.